๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China ยท Delayed Price ยท Currency is CNY
26.31
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST

SHA:600993 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,9903,8673,7283,1373,5323,385
Revenue Growth
5.75%3.72%18.85%-11.20%4.35%21.26%
Gross Profit
1,8631,9011,7311,3071,4941,366
Operating Income
672.88644.71587.12384.73494.16453.38
Net Income
594.83581.49528.09443.25478.57464.59
Earnings Per Share
1.391.351.231.031.111.08
EPS Growth
2.32%9.76%19.42%-7.21%2.78%11.34%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Pharmaceutical Business Segment
1,167
Pharmaceutical Industry Division
2,402
Undistributed Amount
22.48
Medical Services Division
421.83
Offsets between Segments
-146.37
Total
3,867

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,5162,5943,1573,0513,3072,679
Total Debt
71.2999.13234.22272.29638.23182.35
Net Cash (Debt)
2,4452,4952,9232,7792,6692,496
Net Cash Growth
-3.98%-14.64%5.19%4.14%6.90%13.90%
Net Cash Per Share
5.705.796.816.466.195.80

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
797.04600.44497.61604.07341.85597.17
Capital Expenditures
-106.45-119.37-203.85-248.36-75.01-65.1
Free Cash Flow
690.59481.07293.76355.7266.84532.07
Free Cash Flow Growth
26.50%63.76%-17.41%33.30%-49.85%123.96%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.68%49.16%46.43%41.68%42.30%40.36%
Operating Margin
16.86%16.67%15.75%12.26%13.99%13.39%
Pretax Margin
18.23%18.34%17.64%16.73%15.83%16.19%
Profit Margin
14.91%15.04%14.17%14.13%13.55%13.73%
FCF Margin
17.31%12.44%7.88%11.34%7.55%15.72%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.7000.7000.6200.4000.3500.350
Dividend Per Share Growth
12.90%12.90%55.00%14.29%0%16.67%
Dividend Yield
2.66%2.50%2.38%1.65%1.55%1.22%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
18.9620.7621.3123.5220.3626.68
Forward PE
17.0316.8718.4721.8021.8021.80
P/FCF Ratio
16.4225.0938.3129.3036.5123.30
PS Ratio
2.843.123.023.322.763.66